U.S. top prescribed drugs based on sales 2023
Humira was the third ranked medicine in the United States based on sales in 2023, generating over 12 billion U.S. dollars in revenue.
AbbVie in healthy position thanks to sales of top products
Spending on Humira in the United States more than doubled between 2014 and 2018. The biopharmaceutical company responsible for the production of the drug, AbbVie, generated global revenues of around 54 billion U.S. dollars in 2023. Humira and Skyrizi were AbbVie’s two top products based on sales in that year, combining for around 40 percent of the company’s total revenue.
How much money is spent on medicines in the United States?
In the United States, total nominal spending on medicines exceeded 600 billion U.S. dollars for the first time in 2022. Sales of branded drugs account for around 84 percent of the market. Drugs can be categorized in several ways, but a common method is to group them by what they are used to treating. In the United States, cancer, diabetes, and immunology are among the leading therapeutic categories based on sales.
